PCSK9 and Alzheimer disease: In this work, for the first time, we provide in vitro data suggesting that PCSK9 may affect the brain cholesterol metabolism, leading to impaired neuron cholesterol supply and reduced intracellular cholesterol content, with potentially important implications for AD development.